Genzyme Corporation (GENZ) Withdraws Bioenvision (BIVN)'s European Filing of Evoltra(R) in Elderly AML Patients Will Resubmit With New Data from Ongoing Studies
3/19/2008 11:05:27 AM
More...
|
Genzyme Corporation (GENZ) Gets Bioenvision (BIVN) for $345 Million
10/23/2007 11:47:02 AM
More...
|
Delaware Court Approves Bioenvision (BIVN) and Genzyme Corporation (GENZ) Joint Petition Special Meeting to be Reconvened on October 22
10/11/2007 11:24:40 AM
More...
|
Bioenvision (BIVN) and Genzyme Corporation (GENZ) File Petition in Delaware Court
10/10/2007 10:25:35 AM
More...
|
Bioenvision (BIVN) and Genzyme Corporation (GENZ) (Jobs) Seek to Reopen Vote on Merger
10/10/2007 7:03:08 AM
More...
|
Bioenvision (BIVN) Adjourns Special Meeting of Stockholders
10/5/2007 12:21:26 PM
More...
|
Bioenvision (BIVN) Final Vote to Take Place at October 5 Special Meeting of Stockholders
10/5/2007 10:41:49 AM
More...
|
Genzyme Corporation (GENZ) Affirms Purchase Price for Bioenvision (BIVN) at $5.60 Per Outstanding Share
9/27/2007 10:57:13 AM
More...
|
Bioenvision (BIVN) Provides Evoltra® (clofarabine) Regulatory Update
8/20/2007 4:29:27 PM
More...
|
Bioenvision (BIVN) Says Securities Class Action Litigation Without Merit
7/27/2007 11:40:35 AM
More...
|
|